Hyoscyamine, an anticholinergic drug, may allow some patients who would otherwise require a pacemaker for slow ventricular response during atrial fibrillation (AF) to avoid it, a case report suggests.

Although currently the diseased states involving the AVJ are readily treated with either pacemaker placement for conduction disease and ablation for AVNRT, new opportunities for advances in the field ...